Literature DB >> 19856446

MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise.

Penelope Garrood1, Kieren G Hollingsworth, Michelle Eagle, Benjamin S Aribisala, Daniel Birchall, Kate Bushby, Volker Straub.   

Abstract

PURPOSE: To quantify the differences between normal and corticosteroid-treated Duchenne muscular dystrophy (DMD) lower limb muscle using signal intensity measurements on T(1)-weighted and gadolinium contrast-enhanced images and by measurement of muscle T(2) values, and to investigate the effect of exercise.
MATERIALS AND METHODS: Eleven ambulant boys with DMD were imaged at 3 Tesla (T(1)-weighted, gadolinium enhancement and T(2) measurement) before stepping exercise and again (gadolinium, T(2) measurement) 4 days later and were compared with five healthy controls imaged 4 days before and after stepping exercise. Muscle region-of-interest signal intensities were referenced to external oil and gadolinium phantoms.
RESULTS: DMD thigh muscle T(2) values were significantly higher than normal values with the exception of the gracilis muscle. Eight of nine muscles studied showed a significant increase in T(1)-w signal intensity in DMD as compared to normal muscle, suggestive of increased fat infiltration in DMD muscle. In the DMD boys, an exercise effect (increased contrast enhancement) was only seen for the tibialis anterior muscle.
CONCLUSION: Referenced signal intensity measurements may be used to quantify differences between dystrophic and normal muscle without T(1) mapping. Stepping exercise does not have a large impact on subsequent MR imaging of dystrophic muscle.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19856446     DOI: 10.1002/jmri.21941

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  19 in total

Review 1.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

Review 2.  Quantitative proton MR techniques for measuring fat.

Authors:  H H Hu; H E Kan
Journal:  NMR Biomed       Date:  2013-10-03       Impact factor: 4.044

3.  Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease.

Authors:  Bruce M Damon; Ke Li; Richard D Dortch; E Brian Welch; Jane H Park; Amanda K W Buck; Theodore F Towse; Mark D Does; Daniel F Gochberg; Nathan D Bryant
Journal:  J Vis Exp       Date:  2016-12-18       Impact factor: 1.355

Review 4.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

Review 5.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

6.  Quantifying myofiber integrity using diffusion MRI and random permeable barrier modeling in skeletal muscle growth and Duchenne muscular dystrophy model in mice.

Authors:  Kerryanne V Winters; Olivier Reynaud; Dmitry S Novikov; Els Fieremans; Sungheon Gene Kim
Journal:  Magn Reson Med       Date:  2018-03-25       Impact factor: 4.668

7.  Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle.

Authors:  William T Triplett; Celine Baligand; Sean C Forbes; Rebecca J Willcocks; Donovan J Lott; Soren DeVos; Jim Pollaro; William D Rooney; H Lee Sweeney; Carsten G Bönnemann; Dah-Jyuu Wang; Krista Vandenborne; Glenn A Walter
Journal:  Magn Reson Med       Date:  2013-09-04       Impact factor: 4.668

Review 8.  Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy.

Authors:  Erika L Finanger; Barry Russman; Sean C Forbes; William D Rooney; Glenn A Walter; Krista Vandenborne
Journal:  Phys Med Rehabil Clin N Am       Date:  2011-12-14       Impact factor: 1.784

9.  Skeletal muscle water T2 as a biomarker of disease status and exercise effects in patients with Duchenne muscular dystrophy.

Authors:  Ami Mankodi; Noura Azzabou; Thomas Bulea; Harmen Reyngoudt; Hirity Shimellis; Yupeng Ren; Eunhee Kim; Kenneth H Fischbeck; Pierre G Carlier
Journal:  Neuromuscul Disord       Date:  2017-04-28       Impact factor: 4.296

10.  Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression.

Authors:  R J Willcocks; I A Arpan; S C Forbes; D J Lott; C R Senesac; E Senesac; J Deol; W T Triplett; C Baligand; M J Daniels; H L Sweeney; G A Walter; K Vandenborne
Journal:  Neuromuscul Disord       Date:  2014-01-11       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.